TY - JOUR
T1 - Concurrent increases in post-pacing action potential duration and contractility predict occurrence of ventricular arrhythmia
AU - Liu, Chih Min
AU - Lin, Feng Zhi
AU - Chen, Yao Chang
AU - Lin, Yung Kuo
AU - Lu, Yen Yu
AU - Wu, Cheng I.
AU - Higa, Satoshi
AU - Chen, Shih Ann
AU - Chen, Yi Jen
N1 - Funding Information:
This work was supported by grants from the Ministry of Science and Technology (MOST105-2314-B-016-035-MY3, MOST105-2628-B-038-012-MY3, MOST105-2314-B-038-059-MY3, 107-2314-B-281-009, 107-2314-B-038-101-MY3), Taipei Medical University-Wan Fang Hospital (106-eva-02, 106-eva-06, 106-swf-01, 107-wf-swf-01, and 107-wf-eva-01), Cathay General Hospital (107CGH-TMU-05), Chi-Mei Medical Center (107CM-TMU-04), and the Foundation for the Development of Internal Medicine in Okinawa (31-02-003).
PY - 2020/12
Y1 - 2020/12
N2 - Excitation-contraction coupling from the integration of action potential duration (APD) and muscle contractility plays an important role in arrhythmogenesis. We aimed to determine whether distinctive excitation-contraction coupling contributes to the genesis of ventricular tachycardias (VTs). Action potential (AP) and mechanical activity were simultaneously recorded under electrical pacing (cycle lengths from 1000 to 100 ms) in the tissue model created from isolated rabbit right ventricular outflow tracts treated with NS 5806 (10 μM, transient outward potassium current enhancer), pinacidil (2 μM, ATP-sensitive potassium channel opener), and pilsicainide (5 μM, sodium channel blocker). There were 15 (9.9%) inducible VT episodes (group 1) and 136 (90.1%) non-inducible VT episodes (group 2) in our tissue model. Group 1 had greater post-pacing increases of the first occurrence of AP at 90% repolarization (ΔAPD90, p < 0.001) and contractility (ΔContractility, p = 0.003) compared with group 2. Triggered VT episodes were common (72.7%) in cases with a ΔAPD90 > 15% and a ΔContractility > 270%, but were undetectable in those with a ΔAPD90 < 15% and a ΔContractility < 270%. In those with pacing-induced VTs, KB-R7943 (10 μM, a Na+–Ca2+ exchanger inhibitor, NCX inhibitor) significantly reduced the occurrence of VTs from 100.0 to 20.0% (15/15 to 3/15 episodes, p < 0.001). Concurrent increases in both post-pacing APD and contractility resulted in the occurrence of ventricular arrhythmias. NCX inhibition may be a potential therapeutic strategy for ventricular arrhythmias.
AB - Excitation-contraction coupling from the integration of action potential duration (APD) and muscle contractility plays an important role in arrhythmogenesis. We aimed to determine whether distinctive excitation-contraction coupling contributes to the genesis of ventricular tachycardias (VTs). Action potential (AP) and mechanical activity were simultaneously recorded under electrical pacing (cycle lengths from 1000 to 100 ms) in the tissue model created from isolated rabbit right ventricular outflow tracts treated with NS 5806 (10 μM, transient outward potassium current enhancer), pinacidil (2 μM, ATP-sensitive potassium channel opener), and pilsicainide (5 μM, sodium channel blocker). There were 15 (9.9%) inducible VT episodes (group 1) and 136 (90.1%) non-inducible VT episodes (group 2) in our tissue model. Group 1 had greater post-pacing increases of the first occurrence of AP at 90% repolarization (ΔAPD90, p < 0.001) and contractility (ΔContractility, p = 0.003) compared with group 2. Triggered VT episodes were common (72.7%) in cases with a ΔAPD90 > 15% and a ΔContractility > 270%, but were undetectable in those with a ΔAPD90 < 15% and a ΔContractility < 270%. In those with pacing-induced VTs, KB-R7943 (10 μM, a Na+–Ca2+ exchanger inhibitor, NCX inhibitor) significantly reduced the occurrence of VTs from 100.0 to 20.0% (15/15 to 3/15 episodes, p < 0.001). Concurrent increases in both post-pacing APD and contractility resulted in the occurrence of ventricular arrhythmias. NCX inhibition may be a potential therapeutic strategy for ventricular arrhythmias.
KW - Action potential depolarization
KW - Contractility
KW - Na–Ca exchanger inhibitor
KW - Ventricular arrhythmias
KW - Na+–Ca2+ exchanger inhibitor
UR - http://www.scopus.com/inward/record.url?scp=85089357299&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089357299&partnerID=8YFLogxK
U2 - 10.1007/s00424-020-02445-7
DO - 10.1007/s00424-020-02445-7
M3 - Article
AN - SCOPUS:85089357299
SN - 0031-6768
VL - 472
SP - 1783
EP - 1791
JO - Pflugers Archiv European Journal of Physiology
JF - Pflugers Archiv European Journal of Physiology
IS - 12
ER -